ZBIO vs MBX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 04, 2026

ZBIO

54.6
AI Score
VS
ZBIO Wins

MBX

50.9
AI Score

Investment Advisor Scores

ZBIO

55score
Recommendation
HOLD

MBX

51score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric ZBIO MBX Winner
Net Income -377.74M -23.52M MBX
Operating Income -383.06M -27.27M MBX
ROE -156.0% -5.4% MBX
ROA -98.5% -5.2% MBX
Total Assets 383.64M 452.70M MBX
Cash 110.64M 45.21M ZBIO
Current Ratio 5.61 30.79 MBX
Free Cash Flow -172.35M -20.64M MBX

Relative Price Performance (Last 90 Days)

ZBIO 1M: +14.3% · 3M: +60.8% MBX 1M: +11.4% · 3M: +116.3%

Current Technical Phase

ZBIO

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (22.4% over 20 days), RSI 59

RSI (14): 59.3 · Price: $31.13

MBX

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (31.3% over 20 days), RSI 61

RSI (14): 61.3 · Price: $64.41

Fundamentals Snapshot

Metric ZBIO MBX
Market Cap
Forward P/E -13.7 -17.8
Trailing P/E
Revenue (TTM)
Revenue Growth -1.0% 0.0%
Gross Margin
Operating Margin 0.0% 0.0%
EPS -9.10 -2.17
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, ZBIO is currently the stronger investment candidate, winning 1 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.